Skip to content
JournalsWorldThe Global Research Discovery Platform
SCHOLARLY PUBLICATION ✓ Open Access

Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases

Douglas Bruce Kell

📄 Abstract

Background: The production of peroxide and superoxide is an inevitable consequence of aerobic metabolism, and while these particular ‘reactive oxygen species’ (ROSs) can exhibit a number of biological effects, they are not of themselves excessively reactive and thus they are not especially damaging at physiological concentrations.However, their reactions with poorly liganded iron species can lead to the catalytic production of the very reactive and dangerous hydroxyl radical, which is exceptionally damaging, and a major cause of chronic inflammation.Review: We review the considerable and wide-ranging evidence for the involvement of this combination of (su)peroxide and poorly liganded iron in a large number of physiological and indeed pathological processes and inflammatory disorders, especially those involving the progressive degradation of cellular and organismal performance.These diseases share a great many similarities and thus might be considered to have a common cause (i.e.iron-catalysed free radical and especially hydroxyl radical generation).The studies reviewed include those focused on a series of cardiovascular, metabolic and neurological diseases, where iron can be found at the sites of plaques and lesions, as well as studies showing the significance of iron to aging and longevity.The effective chelation of iron by natural or synthetic ligands is thus of major physiological (and potentially therapeutic) importance.As systems properties, we need to recognise that physiological observables have multiple molecular causes, and studying them in isolation leads to inconsistent patterns of apparent causality when it is the simultaneous combination of multiple factors that is responsible.This explains, for instance, the decidedly mixed effects of antioxidants that have been observed, since in some circumstances (especially the presence of poorly liganded iron) molecules that are nominally antioxidants can actually act as pro-oxidants.The reduction of redox stress thus requires suitable levels of both antioxidants and effective iron chelators.Some polyphenolic antioxidants may serve both roles.Understanding the exact speciation and liganding of iron in all its states is thus crucial to separating its various pro-and anti-inflammatory activities.Redox stress, innate immunity and pro-(and some anti-)inflammatory cytokines are linked in particular via signalling pathways involving NF-kappaB and p38, with the oxidative roles of iron here seemingly involved upstream of the IkappaB kinase (IKK) reaction.In a number of cases it is possible to identify mechanisms by which ROSs and poorly BioMed Central Open Access liganded iron act synergistically and autocatalytically, leading to ‘runaway’ reactions that are hard to control unless one tackles multiple sites of action simultaneously.Some molecules such as statins and erythropoietin, not traditionally associated with anti-inflammatory activity, do indeed have ‘pleiotropic’ anti-inflammatory effects that may be of benefit here.Conclusion: Overall we argue, by synthesising a widely dispersed literature, that the role of poorly liganded iron has been rather underappreciated in the past, and that in combination with peroxide and superoxide its activity underpins the behaviour of a great many physiological processes that degrade over time.Understanding these requires an integrative, systems-level approach that may lead to novel therapeutic targets. Background and preambleThe ‘balkanisation’ of the literature is in part due to the amount of it (some 25,000 journals with presently 2.5 million peer-reviewed papers per year, i.e. ~5 per minute [1]), with a number http://www.nlm.nih.gov/ bsd/medline_cit_counts_yr_pub.htmlincreasing by something approaching 2 per minute at PubMed/Medline alone.In addition, the disconnect between the papers in the literature (usually as pdf files) and the metadata describing them (author, journal, year, pages, etc) is acute and badly needs filling [2].Without solving this problem, and without automation of the processes of reading, interpreting and exploiting this literature and its metadata in a digital format, we cannot make use of the existing tools for text mining and natural language processing (e.g.[3-5]), for joining disparate concepts [6], for literature-based discovery (e.g.[7-11], and for studies of bibliometrics [12, 13], literature dynamics [14], knowledge domains [15], detecting republication [16] and so on.Until we recognise these possibilities we are unlikely to seek to realise them.The present article (and see [17] for a preprint) serves to show some of the benefits than can accrue from a more overarching view of the otherwise highly disparate literature in a particular domain (see also [18]), but was done ‘the hard way’, i.e. with a few bibliographic and bibliometric tools but without the kind of automation implied above.For the record, the main tools used (see a review in [2]) were Web of Knowledge and Scopus for literature and citation searching, supplemented by Google Scholar.Some use was also made of 19,20] and GOPubMed [21], as well as various workflows in the Taverna environment [22][23][24][25][26], including the BioAID_DiseaseDiscovery workflow http:// www.myexperiment.org/workflows/72written by Marco Roos.Citations and attendant metadata were stored in Endnote (latterly version X).

📤 Share this page

Found this useful? Share it with your network.

✓ Link copied! Paste it on ResearchGate / Academia.edu